ZA200305155B - Novel receptors for $I (helicobacter pylori) and use thereof. - Google Patents

Novel receptors for $I (helicobacter pylori) and use thereof.

Info

Publication number
ZA200305155B
ZA200305155B ZA200305155A ZA200305155A ZA200305155B ZA 200305155 B ZA200305155 B ZA 200305155B ZA 200305155 A ZA200305155 A ZA 200305155A ZA 200305155 A ZA200305155 A ZA 200305155A ZA 200305155 B ZA200305155 B ZA 200305155B
Authority
ZA
South Africa
Prior art keywords
helicobacter pylori
novel receptors
receptors
novel
pylori
Prior art date
Application number
ZA200305155A
Other languages
English (en)
Inventor
Halina Miller-Podraza
Susann Teneberg
Jonas Aangstroem
Karl-Anders Karlsson
Jari Natunen
Original Assignee
Biotie Therapies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Corp filed Critical Biotie Therapies Corp
Publication of ZA200305155B publication Critical patent/ZA200305155B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA200305155A 2001-01-19 2002-01-18 Novel receptors for $I (helicobacter pylori) and use thereof. ZA200305155B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20010118A FI20010118A7 (fi) 2001-01-19 2001-01-19 Uudet helicobacter pylori reseptorit ja niiden käyttö

Publications (1)

Publication Number Publication Date
ZA200305155B true ZA200305155B (en) 2004-07-19

Family

ID=8560066

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200305155A ZA200305155B (en) 2001-01-19 2002-01-18 Novel receptors for $I (helicobacter pylori) and use thereof.

Country Status (19)

Country Link
US (1) US20040096465A1 (enExample)
EP (1) EP1359922A1 (enExample)
JP (1) JP2004519459A (enExample)
KR (1) KR100886777B1 (enExample)
CN (1) CN100455290C (enExample)
AU (1) AU2002229792B2 (enExample)
CA (1) CA2434350A1 (enExample)
CZ (1) CZ20031914A3 (enExample)
EE (1) EE200300339A (enExample)
FI (1) FI20010118A7 (enExample)
HU (1) HUP0302790A3 (enExample)
IL (1) IL156992A0 (enExample)
NO (1) NO20033270L (enExample)
NZ (1) NZ526906A (enExample)
PL (1) PL363617A1 (enExample)
RU (1) RU2306140C2 (enExample)
SK (1) SK10042003A3 (enExample)
WO (1) WO2002056893A1 (enExample)
ZA (1) ZA200305155B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20011671A7 (fi) 2001-08-20 2003-02-21 Carbion Oy Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
AU2003201619A1 (en) * 2002-01-18 2003-07-30 Biotie Therapies Corporation Novel binding epitopes for helicobacter pylori and use thereof
JP5219329B2 (ja) * 2002-06-28 2013-06-26 ネステク、リミテッド 下痢の予防又は治療用の医薬組成物
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
WO2004065400A1 (en) * 2003-01-20 2004-08-05 Glykos Finland Oy Novel binding epitopes for helicobacter pylori and use thereof
JP5035787B2 (ja) * 2005-10-04 2012-09-26 焼津水産化学工業株式会社 α−1、4結合型N−アセチルグルコサミン含有O−グリカン型糖鎖の分泌促進剤並びにこれを含有するヘリコバクターピロリ菌を原因とする病態の治療予防剤
JP5140246B2 (ja) * 2006-03-15 2013-02-06 公益財団法人野口研究所 N−アセチルグルコサミンの誘導体を含有するピロリ菌増殖抑制剤
JP5014018B2 (ja) * 2006-10-18 2012-08-29 旭化成ケミカルズ株式会社 ピロリ菌の抑制剤または静菌剤
US8075674B2 (en) 2006-11-30 2011-12-13 Donaldson Company, Inc. Filter apparatus with pulse cleaning and methods for pulse cleaning filters
EP2217246B1 (en) * 2007-11-08 2014-12-17 Nestec S.A. Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
JP5933106B2 (ja) * 2012-03-19 2016-06-08 マックス プランク ゲゼルシャフト ツゥアー フェデルゥン デル ヴィッセンシャフテン エー フォー 炭水化物−糖脂質共役ワクチン
PL2911676T3 (pl) * 2012-10-29 2020-12-28 The Board Of Trustees Of The University Of Arkansas Nowe adiuwanty śluzówkowe oraz systemy dostarczania
CN112023037A (zh) * 2020-09-09 2020-12-04 四川大学 一种聚糖在制备对Hp感染的预防和治疗产品中的应用、产品及制备方法
CN112285338B (zh) * 2020-10-20 2023-04-28 四川大学华西医院 一种copd诊断试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8203925D0 (sv) 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
KR960022566A (ko) * 1994-12-30 1996-07-18 김충환 신규한 아미노올리고당 유도체 및 그의 제조방법
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
JPH1045602A (ja) * 1996-07-31 1998-02-17 Motoyasu Murakami ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−8産生阻害剤
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof

Also Published As

Publication number Publication date
JP2004519459A (ja) 2004-07-02
WO2002056893A1 (en) 2002-07-25
NO20033270D0 (no) 2003-07-18
IL156992A0 (en) 2004-02-08
CN100455290C (zh) 2009-01-28
RU2003125370A (ru) 2005-02-10
CA2434350A1 (en) 2002-07-25
CN1525862A (zh) 2004-09-01
FI20010118L (fi) 2002-07-20
SK10042003A3 (sk) 2003-11-04
RU2306140C2 (ru) 2007-09-20
EP1359922A1 (en) 2003-11-12
FI20010118A0 (fi) 2001-01-19
AU2002229792B2 (en) 2007-08-16
NZ526906A (en) 2005-03-24
EE200300339A (et) 2003-10-15
NO20033270L (no) 2003-09-19
HUP0302790A3 (en) 2010-01-28
HUP0302790A2 (hu) 2003-11-28
KR100886777B1 (ko) 2009-03-04
PL363617A1 (pl) 2004-11-29
US20040096465A1 (en) 2004-05-20
CZ20031914A3 (cs) 2004-04-14
FI20010118A7 (fi) 2002-07-20
KR20040018329A (ko) 2004-03-03
WO2002056893A8 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
GB2378780B (en) Data integrity
GB0222504D0 (en) Improved data procedure
EP1407378A4 (en) IT NETWORKS
GB0121864D0 (en) Turbocharger apparatus
ZA200305155B (en) Novel receptors for $I (helicobacter pylori) and use thereof.
GB0105161D0 (en) Computer network
MXPA03009048A (es) Agonistas de la somatostatina.
AU2003276307A1 (en) High affinity receptors for helicobacter pylori and use thereof
IL161235A0 (en) Fsh composition, its preparation and use
AU2003201619A1 (en) Novel binding epitopes for helicobacter pylori and use thereof
GB0122793D0 (en) Allicin
GB0017149D0 (en) Helicobacter pylori mutants
AP2004002991A0 (en) Delimbing apparatus.
GB0010371D0 (en) Helicobacter pylori antigens
MXPA03007242A (es) Delta-1-pirrolinas para control de pestes.
AU2001268885A1 (en) Helicobacter dd-heptosyltransferase
TW516382U (en) Improved aquiculture device
GB0121208D0 (en) Helicobacter pylori vaccines
GB0010370D0 (en) Helicobacter pylori antigens
AU4789400A (en) (helicobacter pylori) antigens
AU2002328123A1 (en) Helicobacter pylori vaccination
AU2003218933A8 (en) Purified dutpase from helicobacter pylori
ZA200109332B (en) Thermal modulator apparatus.
GB0205018D0 (en) Heliobacter pylori vaccination
CA91759S (en) Computer pointing device